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Molecular Mechanism for Regulation of the Human
Mitochondrial Branched-Chain -Ketoacid
Dehydrogenase Complex by Phosphorylation
E1b and E2b components are specific for the BCKDC,
whereas the E3 component is common among the three
-ketoacid dehydrogenase complexes (Reed et al.,
1985). Reaction steps catalyzed by the three catalytic
components (E1b, E2b, and E3) of BCKDC, which are
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R-CO-COOH  E1b-ThDP →
E1b-R-COH  ThDP  CO2↑ (2)Summary
E1b-R-COH  ThDP  E2b-[lipS2] →
The human mitochondrial branched-chain -ketoacid
E2b-[R-CO-S-lipSH]  E1b-ThDP (3)dehydrogenase complex (BCKDC) is a 4 MDa macro-
molecularmachine comprising three catalytic compo- E2b-[R-CO-S-lipSH]  CoA-SH →
nents (E1b, E2b, and E3), a kinase, and a phosphatase.
R-CO-S-CoA  E2b-[lip(SH)2] (4)The BCKDC overall activity is tightly regulated by
phosphorylation in response to hormonal and dietary E2b-[lip(SH)2]  E3-FAD(S)2 →
stimuli. We report that phosphorylation of Ser292-
E2b-[lipS2]  E3-FAD(SH)2 (5)in the E1b active site channel results in an order-to-
disorder transition of the conserved phosphorylation E3-FAD(SH)2  NAD →loop carrying the phosphoryl serine. The conforma-
tional change is triggered by steric clashes of the E3-FAD(S)2  NADH  H (6)
phosphoryl group with invariant His291- that serves
The E1b component binds thiamin diphosphate (ThDP)as an indispensable anchor for the phosphorylation
and catalyzes the ThDP-mediated decarboxylation ofloop through bound thiamin diphosphate. Phosphory-
-ketoacids (Reaction 2), resulting in an enamine-ThDPlation of Ser292- does not severely impede the E1b-
intermediate (E1b-R-COHThDP), followed by the re-dependent decarboxylation of -ketoacids. However,
ductive transfer of the enamine to the lipoyl moiety cova-the disordered loop conformation prevents phosphor-
lently attached to E2b (abbreviated as E2b-[lipS2]) (Reac-ylatedE1b frombinding theE2b lipoyl-bearing domain,
tion 3). The lipoyl-bearing domain (lip-LBD) carrying thewhich effectively shuts off the E1b-catalyzed reductive
S-acyldihydrolipoamide serves as a “swinging arm”acylation reaction and therefore completely inacti-
(Perham, 2000) to transfer the acyl group from E1b tovates BCKDC. This mechanism provides a paradigm
the E2b active site, where it is converted to acyl-CoAfor regulation ofmitochondrial -ketoacid dehydroge-
(Reaction 4). Finally, the E3 component with a tightlynase complexes by phosphorylation.
bound FAD moiety reoxidizes the dihydrolipoyl moiety
on E2b (E2b-[lip(SH)2]) (Reaction 5), with NAD as theIntroduction
ultimate electron acceptor (Reaction 6). The overall reac-
tion results in the production of branched-chain acyl-The human branched-chain -ketoacid dehydrogenase
CoA, CO2, and NADH from BCKAs (Reaction 1).(BCKD) catalytic machine is a member of the highly
The activities of BCKDC and PDC are regulated post-conserved mitochondrial -ketoacid dehydrogenase
translationally by phosphorylation/dephosphorylationcomplexes comprising the BCKD complex (BCKDC), the
under various dietary conditions and hormonal stimulipyruvate dehydrogenase complex (PDC), and the -keto-
(Reed et al., 1985; Harris et al., 1997). Rats fed low-glutarate dehydrogenase complex (Reed et al., 1985).
protein diets show increased phosphorylation of the he-The BCKDC catalyzes the oxidative decarboxylation of
patic BCKDC (Harris et al., 1986). Starvation and diabe-branched-chain -ketoacids (BCKAs) derived from the
tes stimulate activity of the BCKDC in skeletal muscle bybranched-chain amino acids leucine, isoleucine, and va-
decreasing the degree of phosphorylation of the enzymeline (Chuang and Shih, 2001) (Reaction 1):
complex (Paul and Adibi, 1982). The state of phosphory-
R-CO-COOH  CoA-SH  NAD → (1) lation in the BCKDC was shown to largely correlate with
the expression of the BCKD kinase in tissues, as regu-R-CO-S-CoA  CO2↑  NADH  H
lated by extracellular stimuli (Zhao et al., 1993; Huang
The 4 106 Da BCKDC is organized around a cubic core and Chuang, 1999). The BCKD phosphatase, which de-
comprising 24 lipoyl-bearing dihydrolipoyl transacylase phosphorylates the phosphorylated E1b, has been
(E2b) subunits, with which multiple copies of branched- highly purified from bovine kidney (Damuni and Reed,
chain -ketoacid decarboxylase/dehydrogenase (E1b), 1987) but has not been cloned. The mechanism by which
dihydrolipoamide dehydrogenase (E3), the BCKD ki- BCKD phosphatase regulates activity of the BCKDC is
nase, and the BCKD phosphatase are associated. The presently unknown.
Posttranslational modification of proteins by phos-
phorylation is a ubiquitous regulatory mechanism in*Correspondence: david.chuang@utsouthwestern.edu
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cells (Krebs et al., 1958). The human genome contains
575 protein kinase sequences representing 2% of the
total genome (Lander et al., 2001). The structural basis
for control by phosphorylation has been described
(Johnson and Lewis, 2001). The size of the phosphoryl
group on Ser73 of covalently modified phosducin
causes the disordering of the N-terminal cap of helix
2, resulting in the inability of phosducin to bind Gt
subunits of heterotrimeric G proteins (Gt) in the acti-
vation/inactivation cycle (Gaudet et al., 1999). Phos-
phorylation on Ser14 of homodimeric glycogen phos-
phorylase induces conformational changes of the
N-terminal residues, which results in a 50 A˚ shift of the
serine residue so as to alter its contacts from those of
intra- to intersubunit. This promotes a change in the
orientation of the two subunits and the tertiary structure
at the catalytic sites, leading to the activation of glyco-
gen phosphorylase (Sprang et al., 1988). In contrast, the
phosphorylation of Ser113 in E. coli isocitrate dehydro-
genase does not produce conformational changes in
the active site. Rather, inhibition is achieved by both
charge and steric effects of the phosphoryl serine resi-
due, and these effects block the access of the negatively
charged isocitrate substrate to the active site (Hurley et
Figure 1. Time Course for Inhibition and Phosphoryl Group Incorpo-al., 1990).
ration of Wild-Type and Mutant BCKDCThe regulation of the mammalian PDC by phosphory-
(A) Inactivation of the overall activity of BCKDC. The phosphorylationlation was first described as early as in the late 1960’s
of wild-type E1b (closed circles) and S292A- (open squares),(Linn et al., 1969). Despite this early discovery, the mo-
S302A- (open triangles), as well as S292A-/S302A- (closed dia-
lecular mechanism underlying phosphorylation-induced monds) mutant E1b (90 g each) was carried out in 0.1 ml volume
inactivation of PDC and the cognate BCKDC by specific in the presence of lipoylated E2b (144 g) and maltose binding
protein-tagged rat BCKD kinase (26 g). The phosphorylation reac-mitochondrial protein kinases remains unknown. In the
tion was initiated with the addition of 2 mM MgCl2 and 1 mM ATP.human BCKDC, the two phosphorylation sites Ser292-
Aliquots (10 l) were taken at different times, and the activity of the(site 1) and Ser302- (site 2) (Cook et al., 1984) reside
reconstituted wild-type and mutant BCKDC was assayed.in a highly conserved phosphorylation loop in the E1b
(B) Kinetics for phosphoryl group incorporation into the E1b- sub-
active site (Ævarsson et al., 2000; Fries et al., 2003; Li unit. Phosphorylation of wild-type and mutant E1b proteins was
et al., 2004). Similarly, in the human PDC, the three conducted in 0.1 ml in the presence of lipoylated E2b (72 g) with
wild-type or mutant E1b (45 g) and rat MBP-BCKD kinase (13 g).phosphorylation sites are located in well-ordered loop
The phosphorylation reaction was initiated with the addition of 2regions, as shown in the 1.95 A˚ structure of its pyruvate
mM MgCl2 and 0.4 mM [-32P]ATP (specific activity, 0.1 Ci/mmol).dehydrogenase (E1p) component (Ciszak et al., 2003).
Aliquots (10 l) were taken at indicated times and subjected toIt was proposed that a substitution of Ser264- (phos-
SDS-PAGE. Radioactivity incorporated into the E1b- subunit was
phorylation site 1) with a glutamine in the E1p compo- scanned by storage phosphorimaging.
nent mimics the phosphoryl group in partially inactivat-
ing the overall activity of the human PDC (Korotchkina
and Patel, 2001). However, the structural basis for the
of these mitochondrial catalytic machines. These in-inactivation of human E1p by the apparent size effect
clude heritable Maple Syrup Urine Disease (Chuang andof the glutamine residue has not been deciphered.
Shih, 2001), primary lactic acidosis (Robinson, 2001),In the present study, we use the E1b component of
and type II diabetes (Majer et al., 1998).the human BCKDC as a model to dissect the molecular
mechanism underlying the posttranslational control of
Results and Discussionmitochondrial -ketoacid dehydrogenase complexes by
phosphorylation. Our E1b crystal structures show that
Residue Ser292- Is the Majorphosphorylation of Ser292- results in an order-to-dis-
Phosphorylation Siteorder transition of the loop conformation in the 15 A˚
Phosphorylation of wild-type E1b and a site 2 E1b mu-long active site channel of phosphorylated E1b. This
tant (S302A-), in which only site 1 is phosphorylated,conformational change prevents the binding of lipoyl-
results in a near complete rapid inactivation of the recon-ated lipoyl-bearing domain (lip-LBD) to the E1b active
stituted BCKDC (Reaction 1) in 3.5 min (Figure 1A). Insite and effectively shuts off reductive acylation of lip-
contrast, phosphorylation of site 2 in the S292A- vari-LBD (Reaction 3). By contrast, the ThDP-dependent de-
ant, in which site 1 is abolished, is without effect on thecarboxylation of -ketoacids (Reaction 2) is not severely
reconstituted BCKDC activity over the same time period.impeded. These findings provide a framework for struc-
The S292A-/S302A-mutant, in which both phosphor-ture-based drug designs to intervene the phosphoryla-
ylation sites are abolished, also remains fully active overtion-mediated regulation of -ketoacid dehydrogenase
complexes in disease states caused by the dysfunction the entire incubation period. The time course for incor-
Regulation of BCKDC by Phosphorylation
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Table 1. Kinetic Parameters for the Decarboxylation Reaction Catalyzed by Wild-Type and Phosphorylated and Mutant E1b Proteins
kcat/Km (min1 M1)
E1b Protein Km (KIV) (M)a kcat (min1) (102)
Wild-type 50 	 3 12 	 0.3 24
S302A- 22 	 4 37 	 2 170
S292--PO3 983 	 10 9 	 1 0.9
S292D- 4,896 	 88 99 	 7 2.0
S292E- 593 	 18 7.7 	 0.5 1.3
S292N- 224 	 14 166 	 12 74
S292Q- 0
Phosphorylation and mutational studies on Ser292- (site 1) were carried out with the S302A- mutant, in which phosphorylation site 2 is
abolished. For simplicity, the S302A- substitution is not indicated in the nomenclature.
a KIV, -ketoisovalerate.
poration of the [32P] phosphoryl group from [-32P]ATP tant, designated as S292--PO3 E1b, results in a 20-
fold increase in Km for KIV, with a 25% decrease ininto the two phosphorylation sites was also investigated.
The rate and degree of [32P] incorporation into wild-type kcat compared to the wild-type (Table 1). The S292D-
mutant shows a marked 100-fold higher Km for KIVE1b is in parallel to that of the S302A- (site 2) mutant
(Figure 1B). Only a trace amount of the [32P] label is and an 8-fold higher kcat than the wild-type. The S292E-
mutant shows a 12-fold increase in Km for KIV and aincorporated into site 2 of the S302A- variant in the
same time frame. We have previously shown that E1b small decrease in kcat from the wild-type. An uncharged
residue, such as asparagine or glutamine, was also intro-activity is completely abolished at the end of an 8 min
incubation. Abolition of activity at this time point corre- duced into site 1 to determine the effects of residue size
on E1b-catalyzed decarboxylation. The S292N-mutantsponded to 50% of the maximal [32P] incorporation (Da-
vie et al., 1995), and the endpoint for incorporation was exhibits a 4-fold higher Km for KIV and a 14-fold higher
kcat than the wild-type. Remarkably, the presence of aachieved in 2 hr (data not shown). This finding is consis-
tent with the pioneer study by Sugden and Randle bulky uncharged glutamine residue alone in the S292Q-
substitution is sufficient to completely eliminate E1b-(1978), which reported that the phosphorylation of only
one of the two  chains in the E1p heterotetramer is catalyzed decarboxylation (Table 1).
Using the same assay, we showed previously thatsufficient to inhibit both E1p active sites.
The above results confirm that the phosphorylation substitutions of invariant residues that form a hydrogen
bond network in the conserved phosphorylation loopof Ser292- alone is sufficient and necessary to inacti-
vate the BCKDC, and that Ser302- is a silent phosphor- also result in marked increases in kcat for E1b-catalyzed
decarboxylation for these mutants (Li et al., 2004). Theylation site (Zhao et al., 1994). In the cognate E1p com-
ponent of the bovine PDC, phosphorylation proceeds elevated rates of E1b-catalyzed decarboxylation mea-
sured by DCPIP reduction with the mutants are identicalmarkedly faster at site 1 than at sites 2 and 3, and
phosphorylation at site 1 also correlates closely with to those determined radiochemically by monitoring
14CO2 evolution by using [1-14C]KIV as a substrate in thethe inactivation of PDC (Yeaman et al., 1978). Therefore,
the remaining studies focus on the mechanism by which presence of DCPIP. The Perham group has previously
reported similar results regarding an increased rate ofphosphorylation on Ser292- inactivates the BCKDC.
To ensure that both of its active sites were phosphory- decarboxylation with a reduced activity for reductive
acetylation resulting from limited proteolysis or aminolated, the S302A- E1b mutant was incubated with Mg-
ATP, lipoylated E2b (lip-E2b), and the MBP kinase for 8 acid substitutions in the corresponding loop region of
E1p from Bacillus stearothermophilus (Chauhan et al.,hr and was used in kinetic and crystallographic studies.
2000; Fries et al., 2003).
Phosphorylation on Ser292- Increases
Km without Significantly Affecting kcat Phosphorylation on Ser292- Nullifies
the Overall Activity of BCKDCof E1b-Catalyzed Decarboxylation (Reaction 2)
The E1b-catalyzed decarboxylation (Reaction 2), which The BCKDC was reconstituted with wild-type or phos-
phorylated or mutant E1b in the presence of stoichio-is distinct from the overall activity of the BCKDC (Reac-
tion 1), was assayed in the presence of an artificial elec- metric amounts of lip-E2b and E3. The Km for KIV and kcat
of the BCKDC overall activity (Reaction 1) reconstitutedtron acceptor, 2,6-dichlorophenolindophenol (DCPIP).
Table 1 shows that Km for substrate -ketoisovalerate with the S302A- single mutant are similar to the wild-
type (Table 2). Despite significant E1b-catalyzed decar-(KIV) and kcat (based on the E1b heterotetramer) of the
S302A- mutant are similar to those of the wild-type. boxylation activity (Table 1), phosphorylation of Ser292-
(S292--PO3) in the S302A- mutant completely abol-Therefore, phosphorylation and mutational studies on
site 1 were carried out with the S302A- substitution ishes its overall activity (Reaction 1) (Table 2). The
S292D- substitution produces a reduced (to 18%) kcatpresent in all variants. For simplicity, the S302A- substi-
tution is not included in the nomenclature of these mu- and an over 90-fold higher Km for KIV of the reconstituted
overall activity relative to the wild-type BCKDC, whereastants.
Phosphorylation at site 1 alone with the S302A- mu- the BCKDC activity reconstituted with the S292E- mu-
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Table 2. Kinetic Parameters for the Overall Reaction Catalyzed by the BCKD Complex Reconsituted with Wild-Type, Phosphorylated,
and Mutant E1b
E1b Protein Km (KIV) (M)a kcat (min1) kcat/Km (min1 M1)
Wild-type 48 	 2 198 	 9 4
S302A- 28 	 3 131 	 8 4.6
S292--PO3 0
S292D- 4,381 	 85 35 	 3 0.0079
S292E- 0
S292N- 193 	 14 235 	 10 1.21
S292Q- 0
Phosphorylation and mutational studies on Ser292- (site 1) were carried out with the S302A- mutant, in which phosphorylation site 2 is
abolished. For simplicity, the S302A- substitution is not indicated in the nomenclature.
a KIV, -ketoisovalerate.
tant is abolished. The S292N- variant shows a 4-fold Thus, the reduced affinity of ThDP may explain, in part,
the significantly higher than wild-type Km for KIV dis-higher Km for KIV and an20% higher kcat of the reconsti-
tuted overall activity than the wild-type. The presence of played by these phosphorylated and mutant E1b pro-
teins.the bulky uncharged glutamine residue in the S292Q-
mutant nullifies the overall activity (Table 2), similar to
phosphorylated and S292E- E1b (Table 1). The above Phosphorylation of Ser292- Eliminates
results show that while E1b-catalyzed decarboxylation E1b-Catalyzed Reductive Acylation
is apparently affected by phosphorylation or substitu- The reductive acylation reaction (Reaction 3) catalyzed
tions at Ser292-, the altered kcat values for this reaction by E1b was assayed by using [U-14C]KIV and lip-LBD as
(Table 1) do not necessarily correlate with kcat values substrates, and the rate of radiolabel incorporation into
for the overall activity of the BCKDC reconstituted with the latter substrate was determined. This assay is based
these phosphorylated or mutant E1b proteins. on a combination of Reactions 2 and 3, and this combi-
nation allows the measurement of the latter reaction,
The Presence of a Phosphoryl Group since the former is irreversible and not rate limiting.
on Ser292- Interferes with ThDP Binding The phosphorylation of Ser292- in the S302A-mutant
Binding measurements were based on fluorescence abolishes the reductive acylation activity of this variant
quenching upon the binding of increasing concentra- (Figure 2). A residual or absent reductive acylation activ-
tions of ThDP to E1b (Nemeria et al., 2001). The fluores- ity is also exhibited by the S292Q- and S292E- mu-
cence quenching was corrected for inner filter effects at tants. A markedly lower (11%) than wild-type level of
high ThDP concentrations. The fluorescence quenching reductive acylation activity is present in the S292D-
measurements allow direct determinations of the disso-
ciation constant (Kd) for ThDP binding to wild-type and
mutant E1b, including variants that do not exhibit activity
for E1b-catalyzed decarboxylation (Reaction 2). As
shown in Table 3, phosphorylation of Ser292- in the
S302A- mutant results in a 55-fold higher dissociation
constant than the wild-type. The replacement of Ser292-
with a charged or an uncharged residue invariably in-
creases the dissociation constant by one order of mag-
nitude. The above results are consistent with 5- to 14-
fold increases in Km for ThDP for the E1b site 1 mutants
that exhibit activity for the reconstituted BCKDC (data
not shown). The C2 carbon of ThDP and the putative
substrate binding site (near His146-
) (Ævarsson et al.,
1999) are within 2–3 A˚ of each other (Wynn et al., 2003).
Table 3. Dissociation Constants (Kd) for the Binding of ThDP to Figure 2. Activity Levels for the Reconstituted Overall Reaction and
E1b Proteins as Determined by Fluorescence Quenching Reductive Acylation of Wild-Type, Phosphorylated, and Mutant E1b
ProteinsKd (M) Maximum Quench (%)
The overall activity of the reconstituted BCKDC and the reductiveWild-type 1.6 	 0.1 57.0 	 5.7
acylation of lip-LBD catalyzed by wild-type or mutant E1b was as-S292--PO3 89.3 	 5.8 62.4 	 0.4 sayed as described in the Experimental Procedures. Activity forS292D- 40.3 	 3.2 74.6 	 2.0
reductive acylation is expressed as a percent relative to the wild-S292E- 52.6 	 1.7 73.1 	 2.2
type (2.3 min1). Results are the averages of two independent experi-S292N- 54.4 	 7.1 78.4 	 2.3
ments. The overall BCKDC activity is expressed as percent kcat ofS292Q- 60.9 	 7.0 76.5 	 4.5
the reconstituted wild-type BCKDC (198 	 9 min1) from Table 2.
Regulation of BCKDC by Phosphorylation
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mutant. In contrast, the S292N- variant shows the wild-
type level of reductive acylation activity.
The residual or absent reductive acylation activities
obtained with phosphorylated and mutant E1b show
close parallels to reductions in kcat values of the BCKDC
overall activity reconstituted with these E1b proteins
(Figure 2). The data support the thesis that the reductive
acylation step (Reaction 3) is rate limiting in the overall
reaction (Reaction 1) catalyzed by the BCKDC (Li et al.,
2004, Fries et al., 2003). More significantly, the results
indicate that phosphorylation of Ser292- inactivates
the BCKDC by abolishing the E1b-catalyzed reductive
acylation reaction.
The Phosphoryl Group on Ser292- Prevents E1b
from Binding Lip-LBD
To provide a biochemical basis for the decreased level
or absence of reductive acylation activity in phosphory-
lated or mutant E1b, isothermal titration calorimetry
(ITC) was employed to measure the binding of lip-LBD
to E1b. A typical thermogram (upper panel) and the
binding isotherm (lower panel) for the interactions of lip-
LBD with wild-type E1b show a binding molar ratio of
E1b heterotetramer:lip-LBD monomer of 1:2 (Figure 3).
No heat changes are produced when lip-LBD is titrated
against phosphorylated E1b (S292--PO3), indicating
the absence of binding. The curve-fitting analysis of the
binding isotherm shows a dissociation constant (Kd) of
1.8 105 M for the binding of lip-LBD to wild-type E1b.
The S292N-mutant, which shows a wild-type kcat value
for the overall reaction (Table 2), also binds lip-LBD with Figure 3. The Binding of lip-LBD to Wild-Type and Phosphorylated
a dissociation constant (Kd  2.8  105 M) similar to E1b Measured by Isothermal Titration Calorimetry
the wild-type. The S292D- variant exhibits residual re- Wild-type (in blue) or phosphorylated (in red) E1b protein (75 M)
was titrated with 1.5 mM lip-LBD (residues 1–84) as described in theconstituted BCKDC activity; however, the binding of lip-
Experimental Procedures. The upper panel represents raw isothermLBD to this mutant E1b is too weak to be detected by
data with time obtained over a series of 28 injections with wild-ITC. The S292E- and S292Q- mutants, which do not
type or phosphorylated E1b. The lower panel shows the binding
show reconstituted BCKD activity, also do not produce isotherms plotted against the molar ratio of E1b heterotetramer:lip-
heat changes (H  0) when titrated with lip-LBD, indi- LBD. The data were fit by using ORIGIN v. 7.0 software. For wild-
cating the inability of these mutant E1bs to bind lip- type E1b, the dissociation constant Kd is 2.62  105 M; for phos-
phorylated E1b, there is no detectable binding.LBD, similar to phosphorylated E1b. Since lip-LBD is a
substrate for Reaction 3, the void in interactions be-
tween this domain and phosphorylated, as well as
S292E- and S292Q- mutant E1b, explains the ab- al., 2004). The active site structure of wild-type E1b
sence of reductive acylation activity with these E1b pro- determined at 1.83 A˚ resolution from the E1b-SBD com-
teins. The abrogation of reductive acylation activity re- plex is indistinguishable from that of free C-terminally
sulting from the failure of mutant E1b to bind lip-LBD His6-tagged wild-type E1b determined previously (Wynnwas also observed with the H291A- (Wynn et al., 2003) et al., 2003). SBD binds to the C termini of the two 
and the phosphorylation loop E1b mutants (Li et al., subunits in the E1b heterotetramer. It crosses the 2-fold
2004). crystallographic axis that coincides with the intrinsic 2-
fold E1b |
 dimer axis. The corresponding electron
density is therefore overlapped and averaged and doesPhosphorylation of Ser292- (Site 1) Induces
Order-to-Disorder Transition not allow unambiguous modeling of the SBD portion.
Figure 4A shows the segment corresponding toof the Phosphorylation Loop
To provide a structural basis for the inactivation of the Arg287- to Arg301- of the conserved phosphorylation
loop region (residues 286–314) (Li et al., 2004) in one ofBCKDC by phosphorylation, crystal structures of wild-
type, phosphorylated and mutant human E1b proteins the two identical active site channels for wild-type E1b
in the absence of substrate, which harbors cofactorwere determined by X-ray crystallography. We found
that N-terminally His6-tagged E1b proteins gave higher ThDP. This segment contains Ser292- (phosphoryla-
tion site 1) and a small C-terminal helix with the electronquality crystals when in complex with the subunit bind-
ing domain (SBD) of the human E2b component. These density interrupted between Ser302- (phosphorylation
site 2) and Asp305-. The phosphorylation loop ascrystals are overall similar to those described previously
for free wild-type E1b protein (Wynn et al., 2003; Li et shown covers 1072 A˚2 of the surface area and consti-
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Figure 4. The Phosphorylation Loop and
Bound ThDP against the Surface Contour of
the E1b Active Site Channel Formed by the
 (purple) and the 
 (bronze) Subunits
(A) The wild-type phosphorylation loop (in
green) from the  subunit as viewed down
the 15 A˚ long active site channel. Ser292-
(phosphorylation site 1) is labeled in red.
(B) The wild-type E1b was phosphorylated in
the absence of ThDP and substrate. Crystals
of the phosphorylated E1b-SBD complex
were soaked in the crystallization buffer con-
taining 10 mM Mn-ThDP. The phosphoryla-
tion loop in S292--PO3 E1b is largely disor-
dered, and R287- is only partially ordered.
(C) The loop in the S292D- mutant is also
ordered, in part, through interactions be-
tween Asp292- and Ser294-.
(D) The loop in the S292Q- variant is also
disordered, similar to the S292--PO3
structure.
tutes part of the inner wall for the 15 A˚ deep active site ognition in the E1b active site. This is invariant with
many examples of loops that only become ordered uponchannel. The C2 carbon in the thiazolium ring of cofactor
ThDP is at the bottom of the active site channel. The ligand binding. These include the ATP-lid conformations
in branched-chain -ketoacid dehydrogenase kinaseside chain of Ser292- is buried inside in the ordered
loop conformation. (Machius et al., 2001) and the histidine-protein kinase
CheA (Bilwes et al., 2001), with both conformations pro-The wild-type E1b was phosphorylated in the absence
of ThDP and substrate. Crystals of the phosphorylated moted by ATP binding, as well as the ordered phosphor-
ylation loop in the E1b active site induced by boundE1b-SBD complex were then soaked in a buffer con-
taining 10 mM Mn-ThDP. Figure 4B shows that phos- ThDP (Li et al., 2004; Nakai et al., 2004). The wild-type
binding affinity of the S292N- mutant for lip-LBD sug-phorylation of Ser292- results in a complete absence
of electron density for the loop, except for Arg287- gests a local disruption of the phosphorylation loop that
renders the loop partially flexible, but not to the extentand Tyr286-, which adopts a different conformation
compared to the wild-type (the latter residue was not of an overall disruption that abolishes the determinants
for lip-LBD recognition. The local disruption of the phos-shown in the figure). Since fully phosphorylated E1b is
used in crystallographic studies, the missing electron phorylation loop in the S292N- mutant corresponds to
its markedly reduced affinity for ThDP binding (Table 3).density for the loop reflects a disordered conformation
in the two identical active sites. Thus, the structural data The kcat for E1b-catalyzed decarboxylation is markedly
higher than the wild-type in certain variant E1b proteins,obtained here in the absence of substrate do not shed
light on the flip-flop mechanism between the two active in which the phosphorylation loop conformation is either
ordered (S292D-) or locally displaced and showing in-sites proposed for other ThDP-dependent enzymes
(Ciszak et al., 2003; Lu et al., 2000). A substitution of creased flexibility (S292N-). The results indicate that,
unlike reductive acylation (Reaction 3), a completely or-Ser292- with a small negatively charged aspartic acid
residue maintains an ordered but altered (see below) dered phosphorylation loop is not required for E1b-cata-
lyzed decarboxylation (Reaction 2). However, a localloop conformation (Figure 4C). The replacement of
Ser292- with a large neutral glutamine residue also displacement or an overall disruption of the phosphory-
lation loop could in turn also change the rate of enamine-induces an order-to-disorder transition of the phosphor-
ylation loop (Figure 4D) analogous to that observed in ThDP turnover, resulting in a markedly altered kcat or a
complete absence (S292Q-) of E1b-catalyzed decar-phosphorylated E1b. There is also no electron density
for the phosphorylation loop when Ser292- is changed boxylation activity.
to an asparagine or glutamate residue (data not shown).
The binding site for lip-LBD in the E1b active site Introduction of Negative Charges Alone Does Not
Disrupt the Loop Conformationchannel is unknown. Nonetheless, except for the S292N-
mutant, a good correlation exists between the crystallo- Figure 5A shows the phosphorylation loop (Arg287- to
Arg301-) conformation that, when combined with thegraphically characterized disordering of the phosphory-
lation loop and the inability of E1b to bind lip-LBD (Wynn hydrophobic pocket provided by the 
 subunit, forms
the active site channel of wild-type human E1b. Theet al., 2003; Li et al., 2004). We interpret the results to
indicate that the ordered phosphorylation loop directly -ketoacid substrate, as indicated by an arrow here,
must travel the entire length of the 15 A˚ active siteor indirectly provides the determinants for lip-LBD rec-
Regulation of BCKDC by Phosphorylation
2191
Figure 5. Electron Density Maps of the Phosphorylation Loops in Wild-Type and the S292D- Mutant E1b Proteins
2Fo  Fc electron densities are contoured at 1.0  and overlaid onto the coordinates for the phosphorylation loop. Densities and coordinates




(A) Strong electron density is present for the Ser292- (site 1) of the wild-type structure. Extensive hydrogen bonds exist in the wild-type
structure, including the interaction between the side chain O atom of Ser292- and the main chain amide group of Ser294- (distance 3.0 A˚).
(B) The loop and hydrogen bonds in the wild-type structure are largely retained in the S292D- structure. Strong electron density is also
present for Asp292-, which substitutes Ser292- in maintaining interactions with Ser294- (distance 2.8 A˚). However, the water molecule
(w4) in the wild-type structure is replaced by a nearby Cl ion (silver sphere) in the S292D- mutant structure. The side chain for Y113- in
the S292D- structure represents two distinct conformations, as opposed to a single conformation in this wild-type structure. Two conformers
are also present for the side chain of H146-
 in the S292D- structure. Carbon atoms for the phosphorylation loop are shown in green, while
nonloop residues are shown in cyan. ThDP is shown in cyan, the phosphorous atoms are shown in yellow, the sulfur atoms are shown in
orange, the oxygen atoms are shown in red, and the nitrogen atoms are shown in blue. The arrow depicts an -ketoacid substrate entering
the active site channel. Graphics were generated with PyMol and were rendered within the PyMol program to produce the final figure.
channel to reach the bound cofactor ThDP. An extensive type, as measured by the overall activity of the rat
BCKDC (Zhao et al., 1994). This was supported in thenetwork of interactions mediated through water mole-
cules (w1–w4) exists in the vicinity of Ser292- (phos- present study by an over 20-fold higher Km for KIV in
the S292A- mutant than the wild-type, according tophorylation site 1). His291- and Arg287- interact with
the phosphate oxygens of ThDP through the w1 mole- E1b-catalyzed decarboxylation assayed in the presence
of DCPIP (data not shown).cule (Wynn et al., 2003). Figure 5A shows that the side
chain O atom of Ser292- is hydrogen bonded to the The substitution of Ser292- with a small, negatively
charged aspartic acid retains the local phosphorylationbackbone amide of Ser294- (within 3.0 A˚ distance) and
the w3 water molecule. The elimination of these interac- loop conformation through coordination of the aspartate
side chain O1 to the main chain amide of Ser294-tions in phosphorylated E1b or Ser292- E1b mutants
may impart a local (e.g., the S292N- mutant) or overall (2.8 A˚) and O2 to the w2 water molecule, with other
hydrogen bonds largely remaining intact (Figure 5B).(e.g., S292E- and S292Q-) disruption of the phosphor-
ylation loop. It should also be pointed out that the side Therefore, the phosphorylation loop and the active site
channel conformations are fully maintained with clearchain of Arg114- forms hydrogen bonds to phosphate
oxygen atoms of ThDP and the main chain carbonyl electron density in the S292D- E1b structure. There
are notable structural differences in the S292D-mutantgroup of His291-.
Based on the recently published structure of Thermus compared to the wild-type E1b, however, as it appears
that the w4 water molecule in the wild-type is replacedthermophilus E1b (Nakai et al., 2004), the carboxylate
carbonyl group of substrate -ketoisocaproate forms by a Cl ion (from the crystallization solution). At 1.72 A˚
resolution, one expects to see densities for water mole-hydrogen bonds to side chains of Ser292-and Gln98-

through bridging water molecules, buttressed by an ad- cules if they are present in the vicinity of the Cl ion in
the S292D- mutant. The side chain of His146-’ in theditional interaction with the N2 atom of His291- through
the w2 water molecule in the human E1b structure (Fig- S292D- variant adopts at least two distinguishable
conformers through a rotation around the 1 torsionure 5A). The involvement of Ser292- in stabilizing the
bound -ketoacid substrate is a structural basis for the angle (between C and C) by about 90. The His146-
-
conformer that coordinates to the Cl ion is equivalent tomarkedly increased Km for KIV of phosphorylated and
mutant human E1b proteins (Tables 1 and 2). The substi- the single conformation in the wild-type, which interacts
with the w4 water molecule. Since His146-
 is near thetution of Ser292-with an alanine was previously shown
to also increase the Km for KIV by 10-fold over the wild- putative substrate binding site (Ævarsson et al., 1999),
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Figure 6. Predicted Steric Clashes in Phosphorylated, S292E-, and S292Q- E1b Structures
(A–D) In the (A) phosphorylated, (B) S292E-, (C) S292N-, and (D) S292Q- structures, modeled van der Waals surfaces for the phosphoryl
group or substituted residues, which predict steric clashes with His291-, except Asn292-, are based on coordinates of the wild-type
structure in Figure 5A. These steric clashes result in the destabilization of the hydrogen bond network and therefore disorder the loop.
Conformations for ThDP, Arg114-, and the Cl ion that coordinates to the 4
 amino group on the aminopyrimidine ring of ThDP, His146-
,
and Tyr113- are derived from 2Fo  Fc electron densities.
the dual conformers associated with this residue could, phosphorylation loop (Figure 6A), whereas the region
involving residues Tyr113-, Arg114-, Tyr102-
, andin part, account for the highest Km for KIV of the S292D-
E1b among the mutants studied (Tables 1 and 2). In the His146-
 remains ordered. However, the stabilizing in-
teraction between the Ser292- O atom and the back-ordered loop conformation, Asp292- in the S292D-
variant protrudes into the active site channel and is bone amide of Ser294- in the wild-type is lost. The
entire water molecule-mediated hydrogen bond networkjuxtaposed above the thiazolium ring of the bound ThDP.
The electrostatic repulsion posed by the aspartate resi- is also absent in the phosphorylated E1b structure. The
w4 molecule in wild-type E1b is replaced in phosphory-due in the active site channel is likely to also contribute
to the reduced affinity of the S292D- mutant for the lated E1b by a Cl ion, which coordinates to the side
chain of His146-
, similar to what occurs in the S292D-substrate ketoacid. The negative charge of the aspartate
residue may further interfere with the passage of lip- structure. The side chain of Tyr113- in phosphorylated
E1b, unlike S292D-, now solely coordinates to the ClLBD with the electrophilic dithiolane ring through the
active site channel, which could explain the weak inter- ion and correlates with the disordered loop conforma-
tion. When modeled into the wild-type structure, theaction of the S292D- mutant E1b with lip-LBD as indi-
cated by ITC measurements. The Tyr113- side chain phosphoryl group of phosphorylated Ser292- would
clash with the side chain of His291- (Figure 6A). Sincein the S292D- mutant also assumes two different posi-
tions, with one coordinating to the phosphate oxygen His291- is an indispensable anchor for ThDP (Figure
5A) (Wynn et al., 2003), steric effects on the side chainof ThDP, similar to the wild-type, and the other inter-
acting with the Cl ion. The coordination of one of of His291- could result in the overall disruption of the
phosphorylation loop in phosphorylated E1b, similar toTyr113-’s side chains to the phosphate oxygen of ThDP
is consistent with the ordered conformation of the phos- that observed with the H291A- E1b variant (Wynn et
al., 2003). The disordered loop prevents phosphorylatedphorylation loop in the S292D- variant.
E1b from binding the E2b lipoyl-bearing domain, which
effectively shuts off the E1b-catalyzed reductive acyla-Steric Clashes between the Phosphoryl Group
and His291- Triggers the Disordering of the Loop tion reaction and completely inactivates BCKDC. Since
the loop is disordered in phosphorylated E1b (FigureThe incorporation of a phosphoryl group into the
Ser292- side chain results in disordering of the entire 6A), the negative charges of the phosphoryl Ser292-
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Table 4. Statistical Data for Wild-Type, Phosphorylated, and Mutant E1b
Wild-Type S292D- S292Q- S292E- S292N- S292--PO3
Data Collection
Unit cell (A˚) P3121 P3121 P3121 P3121 P3121 P3121
a  b 143.32 145.31 145.67 145.68 145.67 144.40
c 69.29 69.32 69.19 69.25 69.24 69.01
Wavelength (A˚) 1.0 1.0 1.0 1.0 1.0 1.0
Resolution (A˚) 1.83 1.72 1.73 2.10 1.57 2.00
Measurements 393,457 529,588 443,569 218,173 655,557 285,231
Unique reflections 71,894 89,234 86,997 48,283 117,257 53,838
Completeness (last shell) (%) 99.7 (100) 99.9 (98.8) 98.9 (98.0) 97.5 (71.8) 99.7 (96.1) 96.2 (76.0)
Rmerge (last shell) (%) 10.6 (88.9) 6.2 (64.1) 6.8 (66.7) 9.5 (38.6) 5.1 (45.6) 7.4 (37.8)
I/ (last shell) 16.9 (2.1) 27.2 (1.9) 25.2 (1.9) 14.3 (2.1) 32.9 (2.0) 19.4 (2.3)
Refinement
Number of reflections 70,373/1,493 87,692/1,514 85,526/1,469 46,720/1,542 115,678/1,515 52,347/1,479
(work/test)
Number of atoms
Protein 5,878 5,889 5,638 5,569 5,666 5,558
Solvents 487 656 622 489 744 398
Ions 3 4 4 4 4 4
Ligands 2 2 2 2 2 2
Rwork (last shell) (%) 15.6 (21.7) 15.3 (24.5) 14.7 (25.7) 14.7 (20.1) 14.9 (21.0) 16.0 (21.8)
Rfree (last shell) (%) 19.4 (29.8) 18.9 (29.0) 18.1 (32.1) 19.0 (23.4) 16.6 (23.8) 19.3 (25.6)
Rmsd
Bond length (A˚) 0.020 0.020 0.020 0.019 0.019 0.020
Bond angle () 1.659 1.598 1.697 1.622 1.748 1.744
Mean B value (A˚2)
Protein 24.3 11.9 19.9 22.9 9.23 33.9
Solvents 33.1 33.1 34.3 31.3 35.3 41.3
ThDP 17.7 2.7 9.62 14.6 2.17 21.5
Coordinate error (A˚) 0.077 0.061 0.059 0.097 0.045 0.111
Number of alternative 21 23 15 7 18 6
conformations
Missing residues 1–5; 302– 1–5; 303– 1–6; 288– 1–6; 288– 1–6; 288– 1–6; 288–
305; 1–13 305; 1–13 312; 1–13 312; 1–13 312; 1–13 312; 1–13
side chain, unlike its counterpart in E. coli isocitrate 5A) in the S292N- mutant may promote the release
of water molecules that mediate the hydrogen bonddehydrogenase (Hurley et al., 1990), has little, if any,
effect on the accessibility of substrate ketoacids to the network, and this release may lead to disruption of the
local conformation and displacement of the phosphory-active site channel.
The introduction of a large, negatively charged gluta- lation loop. The hydrogen bond between the side chain
O1 atom of Asn292- and the main chain amide ofmate residue into position 292- also results in a com-
plete disordering of the phosphorylation loop through Ser294- is preserved (data not shown). The fact that
the phosphorylation loop conformation is only minimallysteric clashes with the His291- residue (Figure 6B). The
remaining active site conformations, including the Cl disturbed in the S292N- mutant is consistent with its
near wild-type overall BCKDC activity.ion coordinations, resemble that observed with phos-
phorylated E1b. The structural data explain the com- The size effect of the phosphoryl group on the phos-
phorylation loop conformation as well as catalysis isplete inactivation of the rat BCKDC (Zhao et al., 1994)
and human PDC (Korotchkina and Patel, 2001), when a readily reproduced in the S292Q- mutant (Figure 6D).
In this mutant E1b, glutamine in place of Ser292-wouldglutamate residue replaces the site 1 serine.
result in structural rearrangements in order to avoid ste-
ric clashes with His291-, similar to the effects of theGlutamine Substitution Mimics the Phosphoryl
Group in Disrupting the Phosphorylation Loop phosphoryl group in phosphorylated E1b (Figure 6A).
This could explain the disordering of the loop in thisThe steric effect of phosphoryl Ser292- was further
studied by substitutions with the uncharged residues variant accompanied by the abrogation of reductive
acylation and overall activity, similar to phosphorylatedasparagine and glutamine. The phosphorylation loop is
disordered in the S292N- mutant, with other regions of E1b (Figure 2). The only difference is the complete ab-
sence of decarboxylation activity (Reaction 2) in thethe active site present in ordered conformations (Figure
6C), similar to that seen in the phosphorylated E1b struc- S292Q- mutant as opposed to the reduced corre-
sponding activity in phosphorylated E1b. Since theture. The modeled van der Waals surface shows that
Asn292- would necessitate only minor structural phosphorylation loop is not ordered in both S292Q-
and phosphorylated E1b, more detailed structural in-changes in order to avoid steric interference with
His291-. The absence of the interaction between the sights cannot be provided to explain the difference in
E1b-catalyzed decarboxylation activity between theseSer292- O atom and the w3 water molecule (Figure
Structure
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mutants with C-terminally His6-tagged SBD at a molar ratio of 1:4.two E1b proteins. These results, taken together, estab-
The mixture was concentrated in an Amicon Ultra concentrator (Milli-lish that the size of the phosphoryl group alone is suffi-
pore) to 20 mg/ml in 50 mM Na-HEPES (pH 7.5), 150 mM KCl, 20cient to account for the overall disruption of the phos-
mM DTT, and 5% (v/v) glycerol. Crystals of the E1b-SBD complex
phorylation loop, and this disruption results in the loss were obtained by the hanging-drop vapor diffusion technique at
of E1b-mediated reductive acylation (Reaction 3) and 20C by mixing 3 l protein with 3 l crystallization solution (10%
[w/v] polyethylene glycol 4000, 10% [v/v] 2-methyl-2, 4-pentanediol,the accompanying complete abolishment of BCKDC ac-
and 0.1 M sodium citrate [pH 5.8]) with 0.75 ml crystallization solutiontivity.
in the reservoir. Crystals appeared in 1 day and grew to a maximum
size of 200  1600 m (with the former representing the diagonalExperimental Procedures
dimensions of the hexagonal face) within 10 days. Crystals were
stabilized for 12 hr by soaking in fresh crystallization solution con-Production of Wild-type E1b and Ser292- Mutants
taining 10 mM Mn-ThDP. Mn2 ions were used to replace the Mg2N-terminally His6-tagged wild-type E1b and Ser292- mutants were
required for the binding of ThDP to E1b (Wynn et al., 2003). Crystalsproduced as described previously (Wynn et al., 2000). Forward prim-
were cryo-protected by transfer to the crystallization solution con-ers for producing Ser292- E1b mutants (with nucleotides changed
taining 10% (v/v) glycerol. Crystals were flash-cooled in liquid pro-from the wild-type sequence underlined) were as follows: 5
-CCTA
pane and kept at about 100K during data collection for the humanCAGGATCGGGCACCACGACACCAGTGACGACAGTTC-3
 (S292D),
E1b-SBD complex at beam lines 19ID and 19BM at the Advanced5
-CCTACAGGATCGGGCACCACGAGACCAGTGACGACAGTTC-3

Photon Source, Argonne National Laboratory, Argonne, IL. Data sets(S292E), 5
-CCTACAGGATCGGGCACCACAACACCAGTGACGACA
were processed with the HKL2000 package (Otwinowski and Minor,GTTC-3
 (S292N), and 5
-CCTACAGGATCGGGCACCACCAGACCA
1997). Crystals obtained with this procedure exhibited the symmetryGTGACGACAGTTC-3
 (S292Q). The reverse primer for each mutant
of space group P3121, with cell parameters of approximately 145 is of the complementary sequence to its respective forward primer.
145  69 A˚, and contained one  heterodimer and half of an SBDC-terminally His6-tagged LBD (residues 1–84 of the E2b subunit)
molecule per asymmetric unit. The heterotetrameric molecule ofwas expressed (Chuang et al., 2002) and lipoylated in vitro with D,
E1b was generated by crystallographic symmetry. In the absenceL-thioctic acid (oxidized) by using LplA ligase as described pre-
of substrate, there is no structural heterogeneity in the heterodimerviously (Chuang et al., 2000).
that contains one of the two active sites of the E1b heterotetramer.
They diffracted X-rays to a minimum Bragg spacing (dmin) of 1.57 A˚.Phosphorylation of the S302A- E1b Mutant
The structure of E1b was solved and refined with the program Ref-The phosphorylation reaction mixture contained 50 mM potassium
mac5 from the CCP4 package (CCP4, 1994). The complete refine-phosphate (pH 7.5), 100 mM KCl, 5 mM Mg-ATP, 1 mM benzamidine,
ment statistics are shown in Table 4.as well as the maltose binding protein-tagged rat BCKD kinase,
S302A- mutant E1b, and lipoylated E2b at the molar ratio of
Acknowledgments2:12.5:3.3 or concentrations of 0.64, 2.27, or 3.63 mg/ml, respec-
tively. After incubation at 30C for 8 hr, NaCl was added to the
We thank Clint Moss for valuable technical assistance in this study.mixture to a final concentration of 1 M. The mixture was further
This work was supported by Grants DK-26758 and DK-62306 fromincubated for 30 min to allow for the complete dissociation of E1b
the National Institutes of Health and Grant I-1286 from the Welchfrom E2b and the kinase. Phosphorylated E1b was purified from
Foundation. Use of the Argonne National Laboratory Structural Biol-dissociated E2b and the kinase on Ni-NTA and FPLC HiLoad Super-
ogy Center beamlines at the Advanced Photon Source was sup-dex 200 columns in 50 mM potassium phosphate (pH 7.5), 1 M NaCl,
ported by the U.S. Department of Energy, Office of Energy Research,5% (v/v) glycerol, and 5 mM dithiothreitol.
under Contract No. W-31-109-ENG-38.
Binding Studies by Isothermal Titration Calorimetry
Received: July 28, 2004Human E1b and lip-LBD, both C-terminally His6 tagged, were dia-
Revised: September 13, 2004lyzed exhaustively against the same buffer, and binding measure-
Accepted: September 24, 2004ments were carried out by isothermal titration calorimetry as de-
Published: December 7, 2004scribed previously, except a molar ratio of E1b heterotetramer:
lip-LBD monomer was used (Wynn et al., 2003).
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